"I would like to thank Jenny and Johan for their valuable contributions and for a very good collaboration. Unfortunately, our phase III study did not deliver as we had hoped for, and all current operations are being closed down. I wish both Jenny and Johan the best of luck and am certain that they will be as appreciated in their next endeavors as they have been at InDex," said
For more information:
Phone: +46 8 122 038 50
E-mail: info@indexpharma.com
Publication
The information was submitted for publication through the agency of the contact person set out above at 16.55 CET on
This is an English translation of the Swedish press release. In case of discrepancies between the English translation and the Swedish press release, the Swedish press release shall prevail. Information in this press release is intended for investors.
https://news.cision.com/index-pharmaceuticals/r/ceo-and-cfo-both-to-leave-index-pharmaceuticals,c3952890
https://mb.cision.com/Main/9612/3952890/2698377.pdf
(c) 2024 Cision. All rights reserved., source